Consolidated Statement of Operation - USD ($) $ in Thousands		8 Months Ended	12 Months Ended
		Dec. 31, 2016	Dec. 31, 2017
Income Statement [Abstract]
Research and development expenses		$ 89	$ 309
General and administrative		166	730
Operating loss		255	1,039
Finance Expense		9	104
Net loss		$ 264	$ 1,143
Loss per share:
Basic and diluted net loss per share		$ (0.06)	$ (0.20)
Weighted average number of common stocks used in calculation of net loss per Common share - Basic and diluted	[1]	254,094	4,893,022

[1] 2016 Share data is retroactively adjusted to reflect the reverse stock split (refer to Note 7) and the reverse recapitalization consummated in August 2016.